The Efficacy and Safety of 12 Weeks of Sofosbuvir and Ledipasvir versus Sofosbuvir, Ledipasvir, and Ribavirin in Patients with Chronic Hepatitis C, Genotype 1, Who Have Cirrhosis and Have Failed Prior Therapy: A Systematic Review and Meta-Analysis

Table 2

Cochrane Risk of Bias Assessment for included studies.

	LONESTAR	ELECTRON	ION2	Mizokami
Random sequence generation
Allocation concealment
Blinding
Attrition bias/incomplete outcome data
Reporting bias/selective reporting
Other biases (funding)